Medilines Distributors Incorporated : Amendments to Articles of Incorporation

SECURITIES AND EXCHANGE COMMISSIONSEC FORM 17-C CURRENT REPORT UNDER SECTION 17
OF THE SECURITIES REGULATION CODE
AND SRC RULE 17.2(c) THEREUNDER 1. Date of Report (Date of earliest event reported) Jun 9, 20222. SEC Identification Number CS2002510643. BIR Tax Identification No. 2190756144. Exact name of issuer as specified in its charter MEDILINES DISTRIBUTORS INCORPORATED5. Province, country or other jurisdiction of incorporation Metro Manila, Philippines6. Industry Classification Code(SEC Use Only) 7. Address of principal office 7 Pioneer St. cor. Sheridan St., Brgy. Highway Hills, Mandaluyong CityPostal Code15508. Issuer's telephone number, including area code [phone]/[phone]. Former name or former address, if changed since last report N/A10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA

Title of Each Class	Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
Common	2,750,000,800

11. Indicate the item numbers reported herein Item 9

The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.

Medilines Distributors IncorporatedMEDIC PSE Disclosure Form 4-3 - Amendments to Articles of Incorporation References: SRC Rule 17 (SEC Form 17-C) and
Section 4.4 of the Revised Disclosure Rules

Subject of the Disclosure

Amendments to the Articles of Incorporation

Background/Description of the Disclosure

Approval by the Board of Directors of the Amendment of the Third Article of the Articles of Incorporation of Medilines Distributors Incorporated (the "Company") to change the principal address of the Company to 3rd Flr. Vistamall Hub, C.V. Starr Ave., Pamplona Dos, Las Pinas City from 7 Pioneer St., cor. Sheridan St., Brgy. Highway Hills, Mandaluyong City. The Company will be seeking the approval of the shareholders regarding the matter in its Annual Stockholders' Meeting on 4 July 2022.

Date of Approval by Board of Directors	Jun 9, 2022
Date of Approval by Stockholders	TBA
Other Relevant Regulatory Agency, if applicable	N/A
Date of Approval by Relevant Regulatory Agency, if applicable	N/A
Date of Approval by Securities and Exchange Commission	TBA
Date of Receipt of SEC approval	TBA

Amendment(s)

Article No.	From	To
Third	THIRD: That the place where the principal office of the corporation is to be established at No. 07 Pioneer Street corner Sheridan Street, Brgy. Highway Hills Mandaluyong City.	THIRD: That the place where the principal office of the corporation is to be established is at 3rd Floor Vistamall Hub, C.V. Starr Avenue, Pamplona Dos, Las Pinas City.

Rationale for the amendment(s)

The Articles of Incorporation is being amended in order to reflect the opening of the new office of Medilines Distributors Incorporated.

The timetable for the effectivity of the amendment(s)

Expected date of filing the amendments to the Articles of Incorporation with the SEC	TBA
Expected date of SEC approval of the Amended Articles of Incorporation	TBA

Effect(s) of the amendment(s) to the business, operations and/or capital structure of the Issuer, if any

The proposed change in the location of the principal office is not expected to have any material adverse effect on the business or operations of the Company.

Other Relevant Information

Please see attached SEC Form 17-C Current Report

Filed on behalf by:

Name	Luis Melquiades Garcia III
Designation	Investor Relations and Compliance Officer